Scholars Central

Research articlePublished 31 Jul 2016

Study of liver function abnormalities during statin therapy in a tertiary care center

Authors: Sowmya P., Muthiah N. S., Susshmitha R., Arvinth A.

Journal of Chemical and Pharmaceutical Research

Volume 8 · Issue 7 · Pages 515–519

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The statins are the most effective and best-tolerated agents for treating dyslipidemia. They can reduce all elevated lipids and also modestly raises High density lipoprotein -Cholesterol levels. They can reduce fatal and nonfatal coronary heart disease events, stroke, and total mortality. An open labelled cross sectioned study was conducted in the Department of General Medicine Sree Balaji medical college and hospital , Chrompet during the period of August 2015 to January 2016 .In our study ,patients on Atorvastatin had incidence of 4% abnormal elevation of liver enzymes, and patients on Rosuvastatin had incidence of 2% abnormal elevation of liver enzymes. p value was not significant (p=1).Hence this study shows that statins do not cause significant liver dysfunction and can be safely prescribed for all cases of dyslipidemia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Sowmya P.”
  • BylineArticles whose byline prints “Muthiah N. S.”
  • BylineArticles whose byline prints “Susshmitha R.”
  • BylineArticles whose byline prints “Arvinth A.”